Suriname Tech News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Suriname Tech News.

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

April 2026

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

Press releases published on April 21, 2026

an hour ago

Ascendis Announces Redemption of All $575 Million of Outstanding 2.25% Convertible Senior Notes Due 2028

GlobeNewswire

an hour ago

Veeco Announces Date for First Quarter 2026 Financial Results and Conference Call

GlobeNewswire

an hour ago

Rgenta Therapeutics Announces RGT-61159 Clinical Poster Presentation at the Upcoming 2026 American Society of Clinical Oncology (ASCO) Annual Meeting

GlobeNewswire

an hour ago

Fennec Pharmaceuticals Announces Acceptance of Abstracts at the 2026 ASCO Annual Meeting

GlobeNewswire

an hour ago

BlackLine Announces Date for First Quarter 2026 Earnings Release and Conference Call

GlobeNewswire

an hour ago

CytoDyn Completes Enrollment in Phase 2 Metastatic Colorectal Cancer Study

GlobeNewswire

an hour ago

Oculis Publishes Invitation to the Annual General Meeting

GlobeNewswire

an hour ago

AvePoint to Announce First Quarter 2026 Financial Results on May 7

GlobeNewswire

an hour ago

TELA Bio to Announce First Quarter 2026 Financial Results

GlobeNewswire

an hour ago

Foghorn Therapeutics Presents New Preclinical Data for Selective SMARCA2 Inhibitor FHD-909 and for Selective CBP, EP300 and ARID1B Degrader Programs at the 2026 AACR Annual Meeting

GlobeNewswire

an hour ago

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

an hour ago

Immuneering to Present New Survival Data from First-Line Pancreatic Cancer Patients Treated with Atebimetinib + mGnP in an Oral Presentation at the 2026 ASCO Annual Meeting

GlobeNewswire

an hour ago

PharmAla Issues Q2 Financial Statements and Grants Options

GlobeNewswire

an hour ago

Olema Oncology to Present Initial Clinical Data for OP-3136 at the 2026 ASCO Annual Meeting

GlobeNewswire

an hour ago

Wave Life Sciences Announces Hearing on Proposed Redomiciliation to the United States

GlobeNewswire

an hour ago

NewHydrogen Completes Critical Pre-Pilot Plant Technical Validation

GlobeNewswire

an hour ago

Belite Bio Initiates Rolling Submission of New Drug Application to the U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease

GlobeNewswire

2 hours ago

The System Missing Between Field Operations and Finance Is Here

GlobeNewswire

2 hours ago

Jelly Lean (URGENT REPORT) Is It Legit? Complaints, Official Website, Studies, Ingredients, Benefits, and Customer Warnings

GlobeNewswire

2 hours ago

Fortinet Wins 2026 Google Cloud Partner of the Year Award for Workload Security

GlobeNewswire